Menu
Orthopedics & Traumatology

Fibrous Dysplasia, Polyostotic

ICD-10 Code
Q78.1_1

Developmental anomaly where normal bone is replaced by fibrous bone tissue, affecting multiple bones.

Clinical Presentation & Protocol

Patient Usually Complains Of

Patient presents with a history of polyostotic fibrous dysplasia, reporting [chronic/intermittent] bone pain, localized swelling, and [limp/gait abnormality/deformity]. Symptoms involve [specify sites, e.g., femur, tibia, craniofacial]. No history of recent fracture, though patient notes [previous fractures/asymmetry]. Review of systems negative for constitutional symptoms or endocrine abnormalities (e.g., precocious puberty, café-au-lait spots).

Clinical Examination Findings

Physical examination reveals [bony enlargement/asymmetry/deformity] of the [affected anatomical sites]. Palpation demonstrates firm, non-tender masses consistent with fibrous replacement. Assessment of gait and range of motion shows [limitation/normal function]. Skin examination checked for café-au-lait pigmentation (McCune-Albright syndrome screening). Neurological exam intact; no signs of nerve compression or spinal cord involvement.

Treatment Protocol

Management plan includes: 1. Bisphosphonate therapy (e.g., [Zoledronic acid/Pamidronate]) to manage bone pain and turnover. 2. Orthopedic consultation for evaluation of [impending fracture risk/corrective osteotomy/internal fixation]. 3. Regular monitoring of serum alkaline phosphatase and bone mineral density. 4. Physical therapy for functional optimization. 5. Referral to endocrinology for metabolic screening.

Detailed clinical guide coming soon.